Wave Life Sciences ( (WVE) ) has issued an update.
Wave Life Sciences Ltd. has initiated a $200 million public offering, selling over 23 million ordinary shares and nearly 1.9 million pre-funded warrants. Priced at $8.00 per share and $7.9999 per pre-funded warrant, this offering is expected to considerably extend the company’s operational runway into 2027. The underwriters, led by J.P. Morgan Securities LLC and Leerink Partners LLC, also have a 30-day option to buy additional shares. The closing, contingent on standard conditions, is scheduled for around September 27, 2024.
Find detailed analytics on WVE stock on TipRanks’ Stock Analysis page.
